A increasing interest has emerged around GLP-1 medications, particularly Wegovy, for their ability to treat type 2 diabetes and support weight reduction. These novel therapies, initially developed for diabetes care, have demonstrated remarkable benefits in helping individuals achieve their health targets. While copyright are connected in their mech